High Molecular Remission Rate in Pediatric Patients (pts) with Relapsed/Refractory B-cell Precursor Acute Lymphoblastic Leukemia (r/r ALL) Treated with Blinatumomab: Rialto an Open-Label, Multicenter; Expanded Access Study

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共5页
• 作者

  Locatelli Franco; Zugmaier Gerhard; Bader Peter; Jeha Sima; Schlegel Paul-Gerhardt; Bourquin Jean-Pierre; Handgretinger Rupert; Brethon Benoit; Rossig Claudia; Chen-Santel Christiane;

  展开▼
• 作者单位

  IRCCS Bambino Gesu Childrens Hosp Dept Hematol Oncol &

  Cell &

  Gene Therapy Rome Italy;

  Amgen Res Munich GmbH Munich Germany;

  Univ Childrens Hosp Frankfurt Dept Children &

  Adolescents Frankfurt Germany;

  St Jude Childrens Res Hosp Dept Oncol 332 N Lauderdale St Memphis TN 38105 USA;

  Univ Childrens Hosp Wuerzburg Wurzburg Germany;

  Univ Childrens Hosp Zurich Dept Pediat Oncol Childrens Res Ctr Zurich Switzerland;

  Univ Childrens Hosp Tuebingen Dept Hematol &

  Oncol Tubingen Germany;

  Robert Debre Hosp AP HP Pediat Hematol &

  Immunol Paris France;

  Univ Childrens Hosp Muenster Munster Germany;

  Charite Univ Med Berlin Berlin Germany;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词